ORGENESIS INC (ORGS)
US68619K2042 - Common Stock
Orgenesis Provides Third Quarter 2024 Business Update
GERMANTOWN, Md., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (OTCQX: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to...
Orgenesis Announces Reverse Stock Split
GERMANTOWN, Md., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (Nasdaq:ORGS) (“Orgenesis” or the “Company”) today announced that its Board of...
Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia
Orgenesis’ CD19 CAR-T therapy, ORG-101, had a complete response (CR) of 82% in adults and 93% in pediatric patients with the incidence of severe Cytokine...
Orgenesis Announces Strategic Partnership with Harley Street Healthcare Group to Launch a State-of-the-Art Longevity & Wellness Initiative Globally
The strategic alliance aims to drive new-age innovation in wellness & longevity, backed by an investment commitment of up to $10 million over 3 years into...
ORGS Stock Earnings: Orgenesis Reported Results for Q2 2024
Orgenesis just reported results for the second quarter of 2024.
ORGS Stock Earnings: Orgenesis Reported Results for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Orgenesis (NASDAQ:ORGS) just reported results for the second quarter of 2024.Or...
Orgenesis Provides Second Quarter 2024 Business Update
Acquired GMP-validated platforms for launching proprietary CAR-T, tumor-infiltrating lymphocytes, lentivirus vectors, oncolytic virus cell carriers, and...
ORGS Stock Earnings: Orgenesis Reported Results for Q4 2023
Orgenesis just reported results for the fourth quarter of 2023.
ORGS Stock Earnings: Orgenesis Reported Results for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Orgenesis (NASDAQ:ORGS) just reported results for the fourth quarter of 2023.Or...
ORGS Stock Earnings: Orgenesis Misses Revenue for Q1 2024
ORGS stock results show that Orgenesis missed on revenue for the first quarter of 2024.
ORGS Stock Earnings: Orgenesis Misses Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Orgenesis (NASDAQ:ORGS) just reported results for the first quarter of 2024.Org...
Orgenesis Provides Business Update for the First Quarter of 2024
Accelerates rollout of POCare platform following partnership agreement with Germfree and acquisition regaining full ownership and control over Octomera...
Orgenesis Provides Year End Business Update
Major transformation underway commencing with recent acquisitionreasserting full ownership and control over Octomera Secured a $2.3 million investment...
Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility
ORMOND BEACH, Fla. and GERMANTOWN, Md., April 10, 2024 (GLOBE NEWSWIRE) -- Germfree, a leading innovator in modular cleanroom infrastructure and...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Thursday morning!
Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference
GERMANTOWN, Md., March 18, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (Nasdaq:ORGS) (“Orgenesis” or the “Company”), a global leader in decentralizing cell...
Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes
GERMANTOWN, Md., March 13, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (Nasdaq:ORGS) (“Orgenesis” or the “Company”), a global leader in decentralizing cell...
Orgenesis Inc. Announces $2.3 Million Private Placement
GERMANTOWN, Md., March 04, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global leader in decentralized cell...
Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing
GERMANTOWN, Md., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (Nasdaq:ORGS) (“Orgenesis” or the “Company”), a global leader in decentralized cell and...